stocktools
Offerings // Ernexa Therapeutics Inc.

ERNAW offering history

Every offering-related filing in Ernexa Therapeutics Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Apr 30, 2010.

Last executed offering
Feb 10, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Mar 24, 2026
S-3/A — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
5
S-1/S-3/F-series registrations
DateFilingWhat it means
Mar 30, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 24, 2026S-3/A →REGISTEREDS-3/A registration — capacity to sell shares, not a sale yet
Mar 16, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 10, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 5, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 5, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 4, 2026S-1/A →REGISTEREDS-1/A registration — capacity to sell shares, not a sale yet
Feb 3, 2026S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Jun 18, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 18, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 11, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jun 9, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 29, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 29, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 16, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 3, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Nov 18, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 18, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 18, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 15, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 5, 2024S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Oct 29, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Sep 25, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 24, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 22, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jan 12, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Dec 20, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 23, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 22, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 14, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jul 18, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 2, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 25, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 24, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 17, 2023S-1 →REGISTEREDS-1 registration — capacity to sell shares, not a sale yet
Apr 11, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 21, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 20, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 25, 20228-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 12, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
ERNAW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full ERNAW workspace →
ERNAW offering FAQ

When did ERNAW last execute an offering?

Per SEC filings, Ernexa Therapeutics Inc.'s most recent priced offering document is a 424B5 filed 2026-02-10. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did ERNAW last announce or register an offering?

The most recent registration is a S-3/A filed 2026-03-24. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.